Sunday, June 22, 2025 | 10:08 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

ICMR's new advisory expands use of HCQ but cautions against false security

According to the revised advisory, the report of an in-vitro testing of HCQ for antiviral efficacy showed reduction of infectivity and log reduction in viral RNA copy of SARs-CoV2

hydroxychloroquine
premium

However, the council cautioned that the intake of the medicine should not instill a sense of false security.

Agencies
After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against coronavirus (Covid-19) infection, the central government on Friday revised the advisory on the use of hydroxychloroquine as prophylactic for Covid-19 infections, expanding the use of the medicine for asymptomatic healthcare and frontline workers deployed in non-Covid and Covid-19 areas.

The revised advisory issued by the Indian Council of Medical Research (ICMR) has recommended the use of hydroxychloroquine as a preventive medication for asymptomatic healthcare professionals working in non-Covid-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities.